These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 34027207)

  • 1. A comprehensive review and update on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Coronavirus disease 2019 (COVID-19): what do we know now in 2021?
    Ramphul K; Ramphul Y; Park Y; Lohana P; Dhillon BK; Sombans S
    Arch Med Sci Atheroscler Dis; 2021; 6():e5-e13. PubMed ID: 34027207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).
    Park SE
    Clin Exp Pediatr; 2020 Apr; 63(4):119-124. PubMed ID: 32252141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel zoonotic COVID-19 pandemic: An expected global health concern.
    Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
    J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis, and Investigational Therapeuti.
    Sharma R; Khokhar D; Gupta B; Saxena P; Ghosh KK; Geda AK; Kuca K
    Curr Med Chem; 2021; 28(41):8559-8594. PubMed ID: 33949925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pandemic of Coronavirus Disease 2019 (COVID-19).
    Rashid NN
    Curr Mol Med; 2022; 22(9):761-765. PubMed ID: 34789125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive review of coronavirus disease 2019 (COVID-19).
    Chauhan S
    Biomed J; 2020 Aug; 43(4):334-340. PubMed ID: 32788071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
    Guo YR; Cao QD; Hong ZS; Tan YY; Chen SD; Jin HJ; Tan KS; Wang DY; Yan Y
    Mil Med Res; 2020 Mar; 7(1):11. PubMed ID: 32169119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
    Bchetnia M; Girard C; Duchaine C; Laprise C
    J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Corona-virus-disease-19 Vaccines.
    Hasegawa H
    JMA J; 2021 Jul; 4(3):187-190. PubMed ID: 34414311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus Disease: A Review of a New Threat to Public Health.
    Ramphul K; Mejias SG
    Cureus; 2020 Mar; 12(3):e7276. PubMed ID: 32300496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
    Lai CC; Shih TP; Ko WC; Tang HJ; Hsueh PR
    Int J Antimicrob Agents; 2020 Mar; 55(3):105924. PubMed ID: 32081636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.
    Hon KL; Leung KKY; Leung AKC; Sridhar S; Qian S; Lee SL; Colin AA
    Pediatr Pulmonol; 2020 Jul; 55(7):1584-1591. PubMed ID: 32483934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response.
    Astuti I; Ysrafil
    Diabetes Metab Syndr; 2020; 14(4):407-412. PubMed ID: 32335367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.
    Rabi FA; Al Zoubi MS; Kasasbeh GA; Salameh DM; Al-Nasser AD
    Pathogens; 2020 Mar; 9(3):. PubMed ID: 32245083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comprehensive Review of Coronavirus Disease 2019: Epidemiology, Transmission, Risk Factors, and International Responses.
    Li H; Burm SW; Hong SH; Ghayda RA; Kronbichler A; Smith L; Koyanagi A; Jacob L; Lee KH; Shin JI
    Yonsei Med J; 2021 Jan; 62(1):1-11. PubMed ID: 33381929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review.
    Ortiz-Prado E; Simbaña-Rivera K; Gómez-Barreno L; Rubio-Neira M; Guaman LP; Kyriakidis NC; Muslin C; Jaramillo AMG; Barba-Ostria C; Cevallos-Robalino D; Sanches-SanMiguel H; Unigarro L; Zalakeviciute R; Gadian N; López-Cortés A
    Diagn Microbiol Infect Dis; 2020 Sep; 98(1):115094. PubMed ID: 32623267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs for COVID-19: An Update.
    Ceramella J; Iacopetta D; Sinicropi MS; Andreu I; Mariconda A; Saturnino C; Giuzio F; Longo P; Aquaro S; Catalano A
    Molecules; 2022 Dec; 27(23):. PubMed ID: 36500655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.
    Anand U; Jakhmola S; Indari O; Jha HC; Chen ZS; Tripathi V; Pérez de la Lastra JM
    Front Immunol; 2021; 12():658519. PubMed ID: 34276652
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.